{"filing":{"accession_number":"0001193125-26-282865","cik":"0001627281","ticker":"CLLS","company_name":"Cellectis S.A.","form":"6-K","filing_date":"2026-06-25","report_date":null,"primary_document":"ccls_6-k_agm_vote_result.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1627281/000119312526282865/ccls_6-k_agm_vote_result.htm"},"events":[{"id":13937,"run_id":12389,"accession_number":"0001193125-26-282865","anchor_item_number":"EX-99.1","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This exhibit presents the complete voting results from Cellectis S.A.'s Combined General Meeting of Shareholders, detailing 30 resolutions with vote tallies (For, Against, Vote Withhold), percentages, and quorum information. The resolutions cover material matters including approval of annual and consolidated financial statements, board director renewals, share buyback authorization, multiple capital increase delegations, and equity compensation authorizations. This is a classic shareholder_vote_results disclosure required under Item 5.07 equivalent for foreign private issuers.","company_name":"Cellectis S.A.","ticker":"CLLS","filing_date":"2026-06-25","form":"6-K","submitted_at":null,"items":[{"id":11225,"accession_number":"0001193125-26-282865","item_number":"EX-99.1","item_title":"clls-ex99_1.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This exhibit presents the complete voting results from Cellectis S.A.'s Combined General Meeting of Shareholders, detailing 30 resolutions with vote tallies (For, Against, Vote Withhold), percentages, and quorum information. The resolutions cover material matters including approval of annual and consolidated financial statements, board director renewals, share buyback authorization, multiple capital increase delegations, and equity compensation authorizations. This is a classic shareholder_vote_results disclosure required under Item 5.07 equivalent for foreign private issuers.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-25T20:31:39.258995+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11225,"accession_number":"0001193125-26-282865","item_number":"EX-99.1","item_title":"clls-ex99_1.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This exhibit presents the complete voting results from Cellectis S.A.'s Combined General Meeting of Shareholders, detailing 30 resolutions with vote tallies (For, Against, Vote Withhold), percentages, and quorum information. The resolutions cover material matters including approval of annual and consolidated financial statements, board director renewals, share buyback authorization, multiple capital increase delegations, and equity compensation authorizations. This is a classic shareholder_vote_results disclosure required under Item 5.07 equivalent for foreign private issuers.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-25T20:31:39.258995+00:00","company_name":"Cellectis S.A.","ticker":"CLLS","filing_date":"2026-06-25"}]}